INJECTION SITE SWELLING
Adverse reaction reported in 41,947 FDA reports across 12 drugs.
41,947
Total Reports
12
Drugs Involved
Etanercept
Most Reported Drug
Drugs Associated with INJECTION SITE SWELLING
Drugs where "INJECTION SITE SWELLING" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Etanercept | 23,263 | |
| 2 | Dupilumab | 10,951 | |
| 3 | Glatiramer | 1,707 | |
| 4 | Ixekizumab | 1,637 | |
| 5 | Onabotulinumtoxina | 1,091 | |
| 6 | Galcanezumab-Gnlm | 798 | |
| 7 | Naltrexone | 686 | |
| 8 | Pegvaliase-Pqpz | 531 | |
| 9 | Fremanezumab-Vfrm | 432 | |
| 10 | Asfotase Alfa | 427 | |
| 11 | Romosozumab-Aqqg | 280 | |
| 12 | Cabotegravir | 144 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused injection site swelling. Always consult your healthcare provider.